title: Phase I study of immunotherapy of malignant melanoma by direct gene transfer.
authors.affiliation: Hematology/Oncology Arizona Cancer Center Tucson 85724.
authors.forename: E M
authors.initials: EM
authors.lastname: Hersh
authors.forename: E
authors.initials: E
authors.lastname: Akporiaye
authors.forename: D
authors.initials: D
authors.lastname: Harris
authors.forename: A T
authors.initials: AT
authors.lastname: Stopeck
authors.forename: E C
authors.initials: EC
authors.lastname: Unger
authors.forename: J A
authors.initials: JA
authors.lastname: Warneke
authors.forename: S A
authors.initials: SA
authors.lastname: Kradjian
mesh_terms: D000328:Adult; D000917:Antibody Formation; D002985:Clinical Protocols; D004274:DNA, Recombinant / Q000008:administration & dosage*; D005260:Female; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D015793:HLA-B7 Antigen / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods*; D007258:Informed Consent; D015552:Injections, Intralesional; D008297:Male; D008545:Melanoma / Q000556:secondary* / Q000628:therapy*; D010957:Plasmids; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
chemical_list: D004274:DNA, Recombinant; D015793:HLA-B7 Antigen